Abstract
We have been interested for several years in the development of carrier-dependent antitumor agents. these agents should have the following properties: enhanced antitumor activity compared with the parent compound, decreased toxicity, lack of cross-resistance, and compatibility with the drug carrier.
Original language | English (US) |
---|---|
Pages (from-to) | 437-449 |
Number of pages | 13 |
Journal | Journal of Liposome Research |
Volume | 1 |
Issue number | 4 |
DOIs | |
State | Published - 1990 |
Externally published | Yes |
ASJC Scopus subject areas
- Pharmaceutical Science